Evaluation of a Novel Method for Hematocrit Level Determination
Not Applicable
Terminated
- Conditions
- Healthy
- Interventions
- Other: Blood draw
- Registration Number
- NCT01026883
- Lead Sponsor
- Medical University of Vienna
- Brief Summary
The hematocrit level is defined as the ratio of plasma volume and red blood cell mass. Determination of this level is important for the diagnosis and follow-up of various hematological and renal disorders. In clinical practice, automated hematology analyzers are commonly used.
Recently, a new method for hematocrit level determination has been introduced which employs layered resonant piezoelectric sensors. In the present study this technique will be applied in blood samples of healthy subjects and compared to a standard laboratory method.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- All
- Target Recruitment
- 51
Inclusion Criteria
- Men and women aged between 18 and 80 years
- Men and women will be included in equal parts
- Normal findings in the medical history unless the investigator considers an abnormality to be clinically irrelevant
Exclusion Criteria
- Symptoms of a clinically relevant illness in the 3 weeks before the study day
- Systemic treatment with anticoagulants
- Intake of any medication that could lead to spurious hematocrit values
- Presence of any medical condition that could lead to spurious hematocrit values
- Blood or plasma donation during the previous 3 weeks
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Healthy subjects Blood draw Hematocrit level of each subject will be assessed by two different techniques
- Primary Outcome Measures
Name Time Method Correlation of hematocrit level determined by two different techniques 5 minutes
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Department of Clinical Pharmacology, Medical University of Vienna
🇦🇹Vienna, Austria